Table 3.
Sample number | Sample type | Culture | Conventional PCR and sequencing of the sample | Multi-qPCR assay of the sample | Conventional PCR and sequencing of the isolates of the sample | Comments |
---|---|---|---|---|---|---|
S7 | sp | aba-R; kpn-S | KPC | KPC | KPC (kpn-S) | carbapenemase-producing carbapenem-susceptible Enterobacterales |
S11 | sp | aba-R; ani | NDM | NDM | None | The patient isolated CRE isolates two times within five days of the date of the sample detected by the multi-qPCR assay |
S24 | sp | kpn-S; aba-R | OXA-48-like | OXA-48-like | None | CRE may be a non-dominant isolate |
S28 | sp | eco-S | KPC | KPC | None | The patient isolated CRE isolates two times within five days of the date of the sample detected by the multi-qPCR assay |
S45 | balf | eco-S | OXA-48-like | OXA-48-like | None | The patient isolated CRE isolates three times within five days of the date of the sample detected by the multi-qPCR assay |
S58 | balf | aba-R | KPC | KPC | None | CRE may be a non-dominant isolate |
S59 | sp | pmi-S | NDM | NDM | None | CRE may be a non-dominant isolate |
Abbreviations: sp, sputum; balf, bronchoalveolar lavage fluid; aba, Acinetobacter baumannii; kpn, Klebsiella pneumoniae; ani, Aspergillus niger; eco, Escherichia coli; pmi, Proteus mirabilis; S, susceptible to imipenem and meropenem; R, resistant to imipenem and meropenem (resistant to meropenem instead of imipenem for Morganella morganii, Proteus spp., and Providencia spp.).